Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Namrata Shastri"'
Autor:
Namrata Shastri, Shulagna Sharma, Anushikha Thakur, H. Pai, Arnab Bera, Ramakrishnan Melarkode, Shankara Annegowda, Sneha Trivedi, Deepa Mohan, Abhilashi Sahu, Pradip Nair, Sheija Rohil, Pradeep Kabadi, Ranitendranath Tagore, Rajesh Ullanat, Malini Subbarao, Roshni Thomas, Gaurav R Mehta, Parag Goyal, Roopa Venkatachala, Bhavesh Vats, Chethan Gejjalagere Honnappa, Yatika Gokhale, Umamaheshwara Rao K, Laxmi Adhikari
Publikováno v:
Expert Opinion on Biological Therapy. 22:271-298
BACKGROUND Bevacizumab (BEV) is a recombinant humanized monoclonal immunoglobulin G1 antibody that binds to vascular endothelial growth factor (VEGF)-A and acts as an antiangiogenic agent. It is approved for treatment of many cancer indications, incl